A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 5.63 USD -3.26%
Market Cap: 686.9m USD

Intrinsic Value

The intrinsic value of one AQST stock under the Base Case scenario is 3.05 USD. Compared to the current market price of 5.63 USD, Aquestive Therapeutics Inc is Overvalued by 46%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AQST Intrinsic Value
3.05 USD
Overvaluation 46%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation History
Aquestive Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about AQST?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is AQST valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Aquestive Therapeutics Inc.

Explain Valuation
Compare AQST to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AQST?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Aquestive Therapeutics Inc

Current Assets 151.7m
Cash & Short-Term Investments 129.1m
Receivables 11.8m
Other Current Assets 10.8m
Non-Current Assets 11.9m
PP&E 8.7m
Other Non-Current Assets 3.2m
Current Liabilities 25.6m
Accounts Payable 10.9m
Accrued Liabilities 5.7m
Other Current Liabilities 9m
Non-Current Liabilities 142.1m
Long-Term Debt 29.9m
Other Non-Current Liabilities 112.2m
Efficiency

Free Cash Flow Analysis
Aquestive Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Aquestive Therapeutics Inc

Revenue
43.4m USD
Cost of Revenue
-17.2m USD
Gross Profit
26.2m USD
Operating Expenses
-82.4m USD
Operating Income
-56.2m USD
Other Expenses
-12.7m USD
Net Income
-68.9m USD
Fundamental Scores

AQST Profitability Score
Profitability Due Diligence

Aquestive Therapeutics Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
ROE is Increasing
Exceptional Gross Margin
41/100
Profitability
Score

Aquestive Therapeutics Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

AQST Solvency Score
Solvency Due Diligence

Aquestive Therapeutics Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
49/100
Solvency
Score

Aquestive Therapeutics Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AQST Price Targets Summary
Aquestive Therapeutics Inc

Wall Street analysts forecast AQST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AQST is 10.51 USD with a low forecast of 8.08 USD and a high forecast of 15.75 USD.

Lowest
Price Target
8.08 USD
44% Upside
Average
Price Target
10.51 USD
87% Upside
Highest
Price Target
15.75 USD
180% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Aquestive Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AQST is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

AQST Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one AQST stock?

The intrinsic value of one AQST stock under the Base Case scenario is 3.05 USD.

Is AQST stock undervalued or overvalued?

Compared to the current market price of 5.63 USD, Aquestive Therapeutics Inc is Overvalued by 46%.

Back to Top